HealthDay - "New Drug Boosts 'Good' Cholesterol in Study Patients"

 – September 13, 2011 /Press Release/  –– 

A treatment currently being studied may prevent progression of atherosclerosis, a condition caused by the build-up of plaque in artery walls that can lead to heart attack, according to new research. In conducting the study, published in the September 12 issue of The Lancet, researchers followed 130 patients with atherosclerosis who were randomly assigned to be treated with either the experimental heart drug dalcetrapib, or an inactive placebo over the course of two years. Learn more.